Connection

KEPING XIE to Epithelial-Mesenchymal Transition

This is a "connection" page, showing publications KEPING XIE has written about Epithelial-Mesenchymal Transition.
Connection Strength

1.299
  1. Kr?ppel-like Factor 4 Suppresses Serine/Threonine Kinase 33 Activation and Metastasis of Gastric Cancer through Reversing Epithelial-Mesenchymal Transition. Clin Cancer Res. 2018 05 15; 24(10):2440-2451.
    View in: PubMed
    Score: 0.415
  2. FOXM1c promotes pancreatic cancer epithelial-to-mesenchymal transition and metastasis via upregulation of expression of the urokinase plasminogen activator system. Clin Cancer Res. 2014 Mar 15; 20(6):1477-88.
    View in: PubMed
    Score: 0.314
  3. Regulation of EMT by KLF4 in gastrointestinal cancer. Curr Cancer Drug Targets. 2013 Nov; 13(9):986-95.
    View in: PubMed
    Score: 0.309
  4. Vitamin D receptor signaling and pancreatic cancer cell EMT. Curr Pharm Des. 2015; 21(10):1262-7.
    View in: PubMed
    Score: 0.084
  5. Dysregulated Kr?ppel-like factor 4 and vitamin D receptor signaling contribute to progression of hepatocellular carcinoma. Gastroenterology. 2012 Sep; 143(3):799-810.e2.
    View in: PubMed
    Score: 0.070
  6. A novel FoxM1-caveolin signaling pathway promotes pancreatic cancer invasion and metastasis. Cancer Res. 2012 Feb 01; 72(3):655-65.
    View in: PubMed
    Score: 0.068
  7. Hippo transducer TAZ promotes epithelial mesenchymal transition and supports pancreatic cancer progression. Oncotarget. 2015 Nov 03; 6(34):35949-63.
    View in: PubMed
    Score: 0.022
  8. Hyperglycemia as a mechanism of pancreatic cancer metastasis. Front Biosci (Landmark Ed). 2012 01 01; 17(5):1761-74.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.